why women with low risk of dcis may not need surgery
Published 3 years ago • 1.8K plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
4:03
what treatment should women with dcis think about?
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
1:59
dr. rakovitch on predicting risk of recurrence for women with dcis
-
17:37
dcis breast cancer: learn what you need to know
-
0:57
dr. schnabel discusses the dcis recurrence score
-
6:51
recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
-
0:41
q&a: i’m a 37-year-old female, [and] was diagnosed with dcis this past may. cancer does not run ...
-
14:29
multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
-
1:15
the use of radiotherapy for the treatment of breast cancer
-
0:57
predictive biomarkers of recurrence may not be useful for de-escalating treatment in dcis
-
3:20
does dcis raise the risk of breast cancer?
-
7:56
hormonal treatments produce similar quality of life outcomes in dcis
-
4:31
is dcis dangerous or over-treated? how can you manage the risks?
-
6:02
ductal carcinoma in situ, are we over-treating it?
-
4:45
can i tailor my treatment for dcis breast cancer?
-
2:21
breast disease -- risk lesions (pt. 2) dcis
-
5:09
newly diagnosed with dcis, how many patients have a recurrence?
-
35:18
winship grand rounds may 25, 2016: cletus a. arciero, md, facs
-
6:32
no significant difference in recurrence rates among women with dcis taking anastrozole or tamoxifen